Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-016877-14Phase 3Completed
Phase 3, open-label, single-arm trial of influenza vaccine H1N1v in Influenza A infection, sponsored by COPSAC. Primary endpoint: Primary immunogenicity endpoints. Started Oct 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-016877-14.